Article
Liver function in X-linked myotubular myopathy and autosomal dominant centronuclear myopathy: Data of the unite-CNM study.
Journal of neuromuscular diseases - 1 Jul 2025
Colombo S, Cowling B S, Eyler L, Nijkamp D, Freitag C, Thielemans L, Bouman K, Baets J, Vissing J, Quinlivan R, Guglieri M, Montagnese F, Schara-Schmidt U, Dhawan A, Lawlor M W, Voermans N C
Abstract excerpt
BACKGROUND: Centronuclear myopathies represent a subset of debilitating genetic disorders, for which no treatment exists. The Unite-CNM trial (NCT04033159) aimed to assess the effect of an antisense oligonucleotide to reduce DNM2 mRNA expression in X-linked myotubular myopathy (XLMTM) and autosomal dominant centronuclear myopathy (ADCNM). OBJECTIVE: The trial was discontinued due to tolerability concerns (hepatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
